menu
    • menu

    Company profile for Bioxytran

    NEW Drugs in Dev: 5
    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

    Virtual Booth

    Contact Supplier

    Cosma S.p.A., part of CFM Group with AMSA & Clarochem, provides global pharma & veterinary health with 300+ tons of FDA-approved APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Bioxytran is a company focused on developing treatments for stroke and Ischemia. More than 140,000 deaths occur each year due to stroke. Sign up to learn more about BioxyTran and join the fight, because when it comes to stroke, every second counts.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    BioxytranUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    233 Needham Street Suite 300 Newton, MA, 02464
    Telephone
    Telephone
    617-454-1199
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.bioxytraninc.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/bioxytran-inc
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    SCOPE Summit

    SCOPE Summit

    Not Confirmed

    envelop Contact Supplier

    SCOPE Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Bioxytran, University Of Minnesota Collaborate
    Bioxytran, University Of Minnesota Collaborate

    02 Feb 2026

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/biotechnology/bioxytran-and-university-of-minnesota-launch-sponsored-research-collaboration-to-adva-1131966

    ACCESSWIRE
    02 Feb 2026
    Share Share
    Bioxytran Highlights Momentum In Multi-Platform Pipeline Update
    Bioxytran Highlights Momentum In Multi-Platform Pipeline Update

    30 Jan 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-01-30/bioxytran-provides-corporate-update-highlighting-momentum-across-its-multi-platform-pipeline

    PHARMIWEB
    30 Jan 2026
    Share Share
    Bioxytran Advances Pipeline in Corporate Update
    Bioxytran Advances Pipeline in Corporate Update

    29 Jan 2026

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/biotechnology/bioxytran-provides-corporate-update-highlighting-momentum-across-its-multi-platform-p-1131467

    ACCESSWIRE
    29 Jan 2026
    Share Share
    Bioxytran Announces Stock Coverage by Independent Research Firm
    Bioxytran Announces Stock Coverage by Independent Research Firm

    13 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/13/3187744/0/en/Bioxytran-Announces-Initiation-of-Coverage-of-its-Stock-by-Independent-Research.html

    GLOBENEWSWIRE
    13 Nov 2025
    Share Share
    Bioxytran Wraps Up Trial For Broad-Spectrum Antiviral Drug
    Bioxytran Wraps Up Trial For Broad-Spectrum Antiviral Drug

    29 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/29/3176556/0/en/Bioxytran-Completes-Randomized-Clinical-Trial-For-its-Broad-Spectrum-Antiviral-Drug.html

    GLOBENEWSWIRE
    29 Oct 2025
    Share Share
    Bioxytran Reveals Precision Diagnostics for Tissue Oxygenation
    Bioxytran Reveals Precision Diagnostics for Tissue Oxygenation

    15 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/15/3134402/0/en/Bioxytran-Unveils-Revolutionary-Precision-Diagnostics-on-Tissue-Oxygenation.html

    GLOBENEWSWIRE
    15 Aug 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search